Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

DeepSeek was tasked with selecting two stocks investors can buy now and hold long-term due to their growth potential.

With an estimated 1.5 lakh cases of oral cancer diagnosed annually in India and a high mortality rate due to late detection, ...

Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) ...

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

在优化的反应条件下，系统地验证了RECOGNIZER的检测性能。RECOGNIZER对核酸片段的最低检出限达5.42 ...

女性天生拥有两条X染色体，一条遗传自母亲，一条遗传自父亲。不过，为了确保基因表达的平衡，女性体内的每个细胞都会随机遗传其中一条X染色体，另一条则会关闭或失活。 照理来说，X染色体要么来自爸爸，要么来自妈妈，这种随机性应该很公平，但实际上，其背后却上演着一场场激烈的“表达权拉锯战”，其输赢可能影响人的一生。 其实，在人类遗传中存在一个常见的、并不公平的现象：在某些情况下，一些女性体内的X染色体会偏向 ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

北京时间2025年01月24日03时58分，Editas Medicine, Inc.（EDIT.us）股票出现波动，股价快速 拉升 5.14%。截至发稿，该股报1.41美元/股，成交量241.093万股， 换手率 2.92%，振幅9.33%。